Fresenius Medical Care · 11 hours ago
Hemodialysis Field Service Trainer
Fresenius Medical Care is a leading provider in the medical devices industry, and they are seeking a Hemodialysis Field Service Trainer. The role involves designing and developing technical training curriculum and ensuring employees are trained to manage various medical devices in compliance with company standards.
BiotechnologyHealth CareMedical Device
Responsibilities
Develop, implement and maintain technical training curriculum within the assigned function(s) to ensure all necessary employees are appropriately trained to install, test, calibrate, maintain and/or troubleshoot all applicable devices in compliance with company policies and procedures
Record, distribute and/or file all applicable training documents in a timely and accurate manner
Support the verification and/or validation of technical procedures, computer systems and equipment as required
Coordinate with cross-divisional team management to sufficiently satisfy training requirements for the assigned team(s)
Collaborate with management and applicable cross-divisional SME's to ensure training requirements are fulfilled in a timely and accurate manner
Assist with various projects as assigned by direct supervisor
Qualification
Required
Bachelor's Degree required
2 - 5 years' related experience; or an advanced degree without experience; or equivalent directly related work experience
Prior experience in field service, technical support, service management and/or manufacturing
Good time management skills with the ability to multitask concurrent priorities in an organized manner
Strong interpersonal skills with the ability to interact with diverse audiences through professionalism, diplomacy and tact
Strong oral and written communication skills to effectively communicate with all levels of management
Preferred
Experience in a dialysis environment desirable
Prior training experience desirable
Company
Fresenius Medical Care
Fresenius Medical Care is a healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Funding
Current Stage
Public CompanyTotal Funding
$758.43M2025-11-17Post Ipo Debt· $579.5M
2025-07-21Post Ipo Equity· $4.86M
2020-02-25Post Ipo Equity· $6.07M
Leadership Team
Recent News
2025-11-19
2025-11-11
Company data provided by crunchbase